ScienceDaily
Your source for the latest research news
Follow Facebook Twitter LinkedIn Subscribe RSS Feeds Newsletters
New:
  • Black Death Shaped Evolution of Immunity Genes
  • Methane-Eating 'Borgs' Taking Earth's Microbes
  • Pain Relief Without Side Effects and Addiction
  • Accounting For Dark Energy and Dark Matter
  • Meet the First Neanderthal Family
  • Physicists Confirm Hitch in Proton Structure
  • Five Hours' Sleep a Night: Disease Risk
  • Energetics of Piercing Fangs and Claws
  • Hair Straightening Chemicals and Uterine Cancer
  • Ostriches With Similar Interests Form Groups
advertisement
Follow all of ScienceDaily's latest research news and top science headlines!
Science News
from research organizations

1

2

New approach to combat viral infections identified

Date:
November 9, 2012
Source:
University of Pennsylvania
Summary:
When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. A study offers a new strategy for enhancing the effects of interferon in fighting off infection.
Share:
FULL STORY

When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. Interferon can also play a role in suppressing tumor growth and the effects of autoimmune diseases, and doctors may use an artificial form of interferon to treat patients with certain cancers or multiple sclerosis. But even this approach sometimes fails when patients' bodies reject the foreign interferon or growing resistant to its effects.

advertisement

A study by scientists from the University of Pennsylvania School of Veterinary Medicine offers a new strategy for enhancing the effects of interferon in fighting off infection. The research suggests that, by targeting a particular molecule in the interferon signaling pathway, specially designed drugs may be able to boost the activity of a person's own interferon, augmenting the immune system's fight against viruses. It's possible that the same drugs might also be effective against some types of cancer and certain autoimmune conditions.

Serge Fuchs, a professor of cell biology in Penn Vet's Department of Animal Biology and director of the School's Mari Lowe Comparative Oncology Center, was the senior author on the paper published in the Proceedings of the National Academy of Sciences.

"The practical significance of our study is a demonstration of the ability to use emerging pharmaceuticals to reactivate an individual's own interferon or to use a reduced dose to get the same effect," Fuchs said.

Christopher Carbone and Hui Zheng of the Department of Animal Biology and John Lewis and Alexander Reiter of the Department of Clinical Studies played leading roles in the study. Additional Penn Vet collaborators were Sabyasachi Bhattacharya, Paula Henthorn and Kendra Bence. Zhong-Yin Zhang of Indiana University School of Medicine and Darren Baker of Biogen Idec also contributed.

The research would have been impossible without the team's comparative-medicine approach, in which they examined the effects of activating the interferon pathway in both human cells and in cats affected by a naturally occurring disease. Mice would normally be the model organism of choice for such a study, but they lack a molecular element of the interferon pathway that humans and cats share.

advertisement

"Mice are very convenient, but they may not always recapitulate human diseases that well," Fuchs said. "Veterinary diseases happen naturally, and they provide a less convenient but a more truthful recapitulation of the human situation."

Interferon fights viruses by binding to an interferon receptor on cells, triggering a cascade of other molecular events and leading to the production of proteins that prevent viruses from reproducing or that stimulate other immune responses. But because too much interferon can harm the host's body, this signaling cascade has a built-in brake: Using a separate molecular pathway, interferon triggers the body's cells to remove its own receptor, so the immune system attack doesn't go on indefinitely.

"It's very important to understand what regulates the responsiveness of cells to interferon, and a major factor is the levels of cell-surface receptors," Fuchs said.

Although the researchers' investigations of these pathways led them to identify a target for improving the body's virus-fighting ability, they didn't set out to discover a drug. Rather, they were attempting to solve a paradox of cell biology.

The paradox rests on the fact that many steps in the interferon-signaling pathway involve adding a molecule of phosphate to proteins in the cascade. Interferon itself promotes the addition of phosphate onto the interferon receptor, yet previous evidence suggested that the receptor resisted being removed by the cell if it had phosphate added. Given that interferon does in fact trigger the removal of its own receptor, the research team hypothesized that another enzyme must be at work in the pathway to remove the phosphate molecule from the receptor so it could be consumed by the body's cells to ramp down the immune-system response to viruses.

advertisement

Performing a screening for this putative enzyme, they identified protein tyrosine phosphatase 1 B (PTP1B) as a likely candidate. In a series of experiments, the researchers confirmed that blocking PTP1B decreased the removal of the interferon receptor. As a result, interferon signaling became enhanced. Using human cells infected with hepatitis C, the researchers found that adding a PTP1B inhibitor allowed smaller doses of interferon to be effective in keeping the virus from reproducing. They demonstrated a similar effect in human cells infected with vesicular stomatitis virus.

Aiding in their work was the fact that pharmaceutical companies have already designed multiple drugs that inhibit the activity of PTP1B but for a completely separate reason than the enzyme's involvement in interferon signaling.

"PTP1B also works on the leptin receptor," Fuchs said. "This is the pathway that regulates satiety, appetite and weight gain. So in the past 10 years there have been massive industrial and academic undertaking to develop PTP1B inhibitors to treat obesity and diabetes."

To see how these PTP1B inhibitors would impact viral infections in a living organism, the researchers could not use mice because mice lack a portion of the receptor that PTP1B acts upon, and so blocking PTP1B does not impact interferon signaling in the same way as it does in humans and other mammals. Instead, they examined five cats that had been enrolled by their owners in the study. Each was suffering from chronic stomatitis, a condition that involves substantial inflammation in the mouth and makes it painful for the cats to eat and groom. The cats received a single injection of a PTP1B inhibitor. Two weeks later, all five showed noticeable reductions in redness and inflammation, providing clinical evidence that these drugs could be used to treat infection.

Fuchs said that what seemed like a drawback in the study -- that it couldn't be effectively modeled in mice -- ended up being a benefit, as naturally occurring diseases in animals such as cat and dogs more closely mimic many human diseases.

Because interferon is known to suppress tumors and help multiple sclerosis patients, the results of this study give the researchers optimism that PTP1B could be a target for anti-cancer and anti-autoimmune disease therapies.

As a next step, they plan to test the PTP1B inhibitors in a model of feline immunodeficiency virus, or the cat version of AIDS, to see if its virus-fighting capabilities can have an effect against that infection.

The study was supported by the National Institutes of Health and the Mari Lowe Center for Comparative Oncology Research at the University of Pennsylvania.

make a difference: sponsored opportunity

Story Source:

Materials provided by University of Pennsylvania. Note: Content may be edited for style and length.


Journal Reference:

  1. C. J. Carbone, H. Zheng, S. Bhattacharya, J. R. Lewis, A. M. Reiter, P. Henthorn, Z.-Y. Zhang, D. P. Baker, R. Ukkiramapandian, K. K. Bence, S. Y. Fuchs. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proceedings of the National Academy of Sciences, 2012; DOI: 10.1073/pnas.1211491109

Cite This Page:

  • MLA
  • APA
  • Chicago
University of Pennsylvania. "New approach to combat viral infections identified." ScienceDaily. ScienceDaily, 9 November 2012. <www.sciencedaily.com/releases/2012/11/121109162020.htm>.
University of Pennsylvania. (2012, November 9). New approach to combat viral infections identified. ScienceDaily. Retrieved October 20, 2022 from www.sciencedaily.com/releases/2012/11/121109162020.htm
University of Pennsylvania. "New approach to combat viral infections identified." ScienceDaily. www.sciencedaily.com/releases/2012/11/121109162020.htm (accessed October 20, 2022).

  • RELATED TOPICS
    • Health & Medicine
      • Multiple Sclerosis Research
      • Immune System
      • Cancer
      • Crohn's Disease
    • Mind & Brain
      • Multiple Sclerosis
      • Depression
      • Disorders and Syndromes
      • Huntington's Disease
advertisement

  • RELATED TERMS
    • H5N1
    • Flu vaccine
    • Natural killer cell
    • Influenza pandemic
    • Avian flu
    • Pandemic
    • Inflammation of the kidney
    • West Nile virus
advertisement

  Print   Email   Share

advertisement

1

2

3

4

5
Most Popular
this week

HEALTH & MEDICINE
Eating Late Increases Hunger, Decreases Calories Burned, and Changes Fat Tissue
Clusters of Genes Help Mice Live Longer
Study of Over 5 Million People's DNA Reveals Genetic Links to Height
MIND & BRAIN
Dogs Can Smell When We're Stressed, Study Suggests
Human Brain Cells in a Dish Learn to Play Pong in Real Time
Healthy Aging Requires an Understanding of Personality Types
LIVING & WELL
Did the Pandemic Change Our Personalities?
Watching TV With Your Child Can Help Their Cognitive Development, Study Suggests
Coffee Drinking Is Associated With Increased Longevity
advertisement

Strange & Offbeat
 

HEALTH & MEDICINE
RNA Origami Enables Applications in Synthetic Biology
Unlocking the Power of Our Emotional Memory
Robotic Drug Capsule Can Deliver Drugs to Gut
MIND & BRAIN
Our Brains Use Quantum Computation
Human Brain Cells in a Dish Learn to Play Pong in Real Time
Dogs Can Smell When We're Stressed, Study Suggests
LIVING & WELL
Researchers Develop Painless Tattoos That Can Be Self-Administered
Washing Dishes With Superheated Steam More Effective, Earth-Friendly
News Addiction Linked to Not Only Poor Mental Wellbeing but Physical Health Too, New Study Shows
Explore More
from ScienceDaily

RELATED STORIES

Common Cold Combats COVID-19, Study Finds
June 15, 2021 — In a new study, the researchers found that the common respiratory virus jump-starts the activity of interferon-stimulated genes, early-response molecules in the immune system which can halt ...
Intranasal Influenza Vaccine Enhances Immune Response and Offers Broad Protection
May 3, 2021 — An influenza vaccine that is made of nanoparticles and administered through the nose enhances the body's immune response to influenza virus infection and offers broad protection against different ...
Novel Indicator of Influenza Immunity
June 3, 2019 — A study of influenza virus transmission in Nicaraguan households reveals new insights into the type of immune responses that may be protective against influenza virus infection, report investigators. ...
Researchers Repurpose Immune-Activating Cytokine to Fight Breast Cancer
Dec. 18, 2017 — The most lethal form of breast cancer could have a new treatment option, according to new research. Researchers showed triple-negative breast cancer cells are highly vulnerable to interferon-beta -- ...
advertisement


SD
  • SD
    • Home Page
    • Top Science News
    • Latest News
  • Home
    • Home Page
    • Top Science News
    • Latest News
  • Health
    • View all the latest top news in the health sciences,
      or browse the topics below:
      Health & Medicine
      • Allergy
      • Alternative Medicine
      • Birth Control
      • Cancer
      • Diabetes
      • Diseases
      • Heart Disease
      • HIV and AIDS
      • Obesity
      • Stem Cells
      • ... more topics
      Mind & Brain
      • ADD and ADHD
      • Addiction
      • Alzheimer's
      • Autism
      • Depression
      • Headaches
      • Intelligence
      • Psychology
      • Relationships
      • Schizophrenia
      • ... more topics
      Living Well
      • Parenting
      • Pregnancy
      • Sexual Health
      • Skin Care
      • Men's Health
      • Women's Health
      • Nutrition
      • Diet and Weight Loss
      • Fitness
      • Healthy Aging
      • ... more topics
  • Tech
    • View all the latest top news in the physical sciences & technology,
      or browse the topics below:
      Matter & Energy
      • Aviation
      • Chemistry
      • Electronics
      • Fossil Fuels
      • Nanotechnology
      • Physics
      • Quantum Physics
      • Solar Energy
      • Technology
      • Wind Energy
      • ... more topics
      Space & Time
      • Astronomy
      • Black Holes
      • Dark Matter
      • Extrasolar Planets
      • Mars
      • Moon
      • Solar System
      • Space Telescopes
      • Stars
      • Sun
      • ... more topics
      Computers & Math
      • Artificial Intelligence
      • Communications
      • Computer Science
      • Hacking
      • Mathematics
      • Quantum Computers
      • Robotics
      • Software
      • Video Games
      • Virtual Reality
      • ... more topics
  • Enviro
    • View all the latest top news in the environmental sciences,
      or browse the topics below:
      Plants & Animals
      • Agriculture and Food
      • Animals
      • Biology
      • Biotechnology
      • Endangered Animals
      • Extinction
      • Genetically Modified
      • Microbes and More
      • New Species
      • Zoology
      • ... more topics
      Earth & Climate
      • Climate
      • Earthquakes
      • Environment
      • Geography
      • Geology
      • Global Warming
      • Hurricanes
      • Ozone Holes
      • Pollution
      • Weather
      • ... more topics
      Fossils & Ruins
      • Ancient Civilizations
      • Anthropology
      • Archaeology
      • Dinosaurs
      • Early Humans
      • Early Mammals
      • Evolution
      • Lost Treasures
      • Origin of Life
      • Paleontology
      • ... more topics
  • Society
    • View all the latest top news in the social sciences & education,
      or browse the topics below:
      Science & Society
      • Arts & Culture
      • Consumerism
      • Economics
      • Political Science
      • Privacy Issues
      • Public Health
      • Racial Disparity
      • Religion
      • Sports
      • World Development
      • ... more topics
      Business & Industry
      • Biotechnology & Bioengineering
      • Computers & Internet
      • Energy & Resources
      • Engineering
      • Medical Technology
      • Pharmaceuticals
      • Transportation
      • ... more topics
      Education & Learning
      • Animal Learning & Intelligence
      • Creativity
      • Educational Psychology
      • Educational Technology
      • Infant & Preschool Learning
      • Learning Disorders
      • STEM Education
      • ... more topics
  • Quirky
    • Top News
    • Human Quirks
    • Odd Creatures
    • Bizarre Things
    • Weird World
Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

  • Email Newsletters
  • RSS Feeds
Follow Us

Keep up to date with the latest news from ScienceDaily via social networks:

  • Facebook
  • Twitter
  • LinkedIn
Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

  • Leave Feedback
  • Contact Us
About This Site  |  Staff  |  Reviews  |  Contribute  |  Advertise  |  Privacy Policy  |  Editorial Policy  |  Terms of Use
Copyright 1995-2022 ScienceDaily or by other parties, where indicated. All rights controlled by their respective owners.
Content on this website is for information only. It is not intended to provide medical or other professional advice.
Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners.
Financial support for ScienceDaily comes from advertisements and referral programs, where indicated.
— CCPA: Do Not Sell My Information — GDPR: Privacy Settings —